CVS Health Corporation CVS
Set alert
90.25 USD -0.08 -0.09%
At close · Oct 30
90.25 0.00 0.00%
After hours · Oct 30, 4:33 PM ET
89.90 Day range 91.95
70.08 52-week range 110.60
- YTD
- +13.72%
- 1 year
- +17.68%
- Open
- 91.95
- Prev close
- 90.33
- Mkt cap
- 115.43B
- Vol
- 8.19M
- Avg vol
- 7.94M
- EPS
- 3.80
- P/E
- 23.75
- Div yield
- 2.94%
More statistics
- Low
- 89.90
- High
- 91.95
- Forward P/E
- 10.60
- Beta
- 0.60
- Short ratio
- 1.63
- Inst. own
- 91.08%
- Dividend
- 2.66
- Ex-div date
- Oct 21, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 91.29
- 200-d avg
- 88.73
- 1y target
- 115.48
5Y chart
Events in this range
- Jan 20, 2022Dividend: 0.55
- Apr 21, 2022Dividend: 0.55
- Jul 21, 2022Dividend: 0.55
- Oct 20, 2022Dividend: 0.55
- Jan 19, 2023Dividend: 0.605
- Apr 20, 2023Dividend: 0.605
- Jul 20, 2023Dividend: 0.605
- Oct 19, 2023Dividend: 0.605
- Oct 20, 2023Dividend: 0.605
- Jan 19, 2024Dividend: 0.665
- Apr 19, 2024Dividend: 0.665
- Jul 22, 2024Dividend: 0.665
- Oct 21, 2024Dividend: 0.665
- Jan 23, 2025Dividend: 0.665
- Apr 22, 2025Dividend: 0.665
- Jul 22, 2025Dividend: 0.665
- Jul 31, 2025Earnings: 1.81; estimate 1.46; surprise 23.97%
- Oct 23, 2025Dividend: 0.665
- Oct 29, 2025Earnings: 1.6; estimate 1.37; surprise 16.79%
- Jan 22, 2026Dividend: 0.665
- Feb 10, 2026Earnings: 1.09; estimate 1; surprise 9%
- Apr 23, 2026Dividend: 0.665
- May 6, 2026Earnings: 2.57; estimate 2.18; surprise 17.89%
- Jul 23, 2026Dividend: 0.665
- Aug 5, 2026Earnings: 2.58; estimate 1.85; surprise 39.46%
- Aug 6, 2026Rating: Evercore ISI Group · Outperform → Outperform
- Aug 6, 2026Rating: UBS · Buy → Buy
- Aug 12, 2026Rating: JP Morgan · Overweight → Overweight
- Aug 19, 2026Rating: Argus Research · Buy → Buy
- Sep 3, 2026Rating: UBS · Buy → Buy
- Oct 12, 2026Rating: Leerink Partners · Outperform → Outperform
- Oct 22, 2026Dividend: 0.665
- Nov 4, 2026Earnings: —; estimate 1.65; surprise —%
Signals (114)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 26, 2026 | 6 days ago |
| SMA: Bearish | Oct 26, 2026 | 6 days ago |
| SMA: Bullish | Oct 19, 2026 | 1 week ago |
| SMA: Bullish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
| RSI: Overbought | Jul 13, 2026 | 3 months ago |
| RSI: Overbought | Jun 8, 2026 | 4 months ago |
| RSI: Overbought | May 11, 2026 | 5 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 6 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| SMA: Bearish | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| MACD: Sell Signal | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Nov 24, 2025 | 11 months ago |
| SMA: Bearish | Nov 10, 2025 | 11 months ago |
| RSI: Overbought | Oct 13, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 18, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | Jul 7, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 7, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 23, 2025 | 1 year ago |
| SMA: Bullish | Jun 9, 2025 | 1 year ago |
| MACD: Sell Signal | May 19, 2025 | 1 year ago |
| SMA: Bearish | May 12, 2025 | 1 year ago |
| SMA: Bullish | Apr 28, 2025 | 1 year ago |
| SMA: Bearish | Apr 21, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| SMA: Bearish | Feb 3, 2025 | 1 year ago |
| SMA: Bullish | Jan 27, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 20, 2025 | 1 year ago |
| SMA: Bullish | Jan 13, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 9, 2024 | 1 year ago |
| SMA: Bearish | Dec 2, 2024 | 1 year ago |
| SMA: Bearish | Dec 2, 2024 | 1 year ago |
| SMA: Bullish | Nov 25, 2024 | 1 year ago |
| SMA: Bullish | Nov 25, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 25, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 11, 2024 | 1 year ago |
| SMA: Bearish | Oct 21, 2024 | 2 years ago |
| SMA: Bearish | Oct 14, 2024 | 2 years ago |
| SMA: Bullish | Sep 30, 2024 | 2 years ago |
| SMA: Bullish | Sep 23, 2024 | 2 years ago |
| SMA: Bearish | Jul 29, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 22, 2024 | 2 years ago |
| SMA: Bullish | Jul 8, 2024 | 2 years ago |
| SMA: Bearish | Jun 24, 2024 | 2 years ago |
| SMA: Bullish | Jun 17, 2024 | 2 years ago |
| RSI: Oversold | Apr 29, 2024 | 2 years ago |
| SMA: Bearish | Apr 8, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 8, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 11, 2024 | 2 years ago |
| SMA: Bearish | Feb 26, 2024 | 2 years ago |
| SMA: Bullish | Feb 5, 2024 | 2 years ago |
| SMA: Bearish | Jan 15, 2024 | 2 years ago |
| SMA: Bullish | Dec 4, 2023 | 2 years ago |
| SMA: Bullish | Dec 4, 2023 | 2 years ago |
| SMA: Bearish | Nov 27, 2023 | 2 years ago |
| SMA: Bullish | Nov 20, 2023 | 2 years ago |
| SMA: Bearish | Nov 6, 2023 | 2 years ago |
| SMA: Bullish | Oct 30, 2023 | 3 years ago |
| SMA: Bearish | Oct 23, 2023 | 3 years ago |
| SMA: Bearish | Oct 16, 2023 | 3 years ago |
| SMA: Bullish | Oct 9, 2023 | 3 years ago |
| SMA: Bullish | Oct 2, 2023 | 3 years ago |
| SMA: Bearish | Sep 25, 2023 | 3 years ago |
| SMA: Bullish | Sep 11, 2023 | 3 years ago |
| SMA: Bearish | Aug 14, 2023 | 3 years ago |
| SMA: Bullish | Jul 10, 2023 | 3 years ago |
| SMA: Bearish | Jun 12, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 12, 2023 | 3 years ago |
| SMA: Bullish | Jun 5, 2023 | 3 years ago |
| RSI: Oversold | May 1, 2023 | 3 years ago |
| RSI: Oversold | Mar 6, 2023 | 3 years ago |
| MACD: Sell Signal | Dec 26, 2022 | 3 years ago |
| SMA: Bearish | Dec 12, 2022 | 3 years ago |
| SMA: Bearish | Dec 12, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 14, 2022 | 3 years ago |
| SMA: Bullish | Oct 31, 2022 | 4 years ago |
| SMA: Bullish | Oct 31, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 26, 2022 | 4 years ago |
| SMA: Bearish | Sep 19, 2022 | 4 years ago |
| SMA: Bearish | Sep 19, 2022 | 4 years ago |
| SMA: Bullish | Sep 5, 2022 | 4 years ago |
| SMA: Bearish | Aug 29, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| MACD: Buy Signal | Aug 1, 2022 | 4 years ago |
| SMA: Bullish | Jul 25, 2022 | 4 years ago |
| SMA: Bearish | Jul 18, 2022 | 4 years ago |
| SMA: Bullish | Jul 11, 2022 | 4 years ago |
| SMA: Bearish | Apr 11, 2022 | 4 years ago |
| SMA: Bullish | Apr 4, 2022 | 4 years ago |
| SMA: Bearish | Mar 28, 2022 | 4 years ago |
| SMA: Bullish | Mar 14, 2022 | 4 years ago |
| SMA: Bearish | Mar 7, 2022 | 4 years ago |
| SMA: Bullish | Feb 28, 2022 | 4 years ago |
| SMA: Bearish | Feb 14, 2022 | 4 years ago |
Key statistics
- Market cap
- 115.70B
- Enterprise value
- 178.07B
- Trailing P/E
- 23.81
- Forward P/E
- 10.60
- PEG ratio
- 0.21
- Price / sales
- 0.28
- Price / book
- 1.45
- EPS (TTM)
- 3.80
- Beta
- 0.60
- Dividend yield
- 2.94%
- Payout ratio
- 70.00%
- Profit margin
- 1.18%
- Revenue (TTM)
- 412.64B
- Revenue growth
- 7.10%
- Free cash flow
- 8.08B
- Total cash
- 13.96B
- Total debt
- 76.31B
- Return on equity
- 6.21%
- Shares outstanding
- 1.28B
- Short % of float
- 1.28%
- 50-day average
- 91.29
- 200-day average
- 88.73
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 115.48 +28.0% upside
Now 90.25
- Target (low)
- 103.00
- Target (mean)
- 115.48
- Target (high)
- 145.00
Ratings (0m) 27 25 buy · 2 hold · 0 sell
- Strong buy7
- Buy18
- Hold2
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 1.65.
Financials — quick view
CVS Revenue — quarterly 106.10B
CVS Net income — quarterly 2.98B
CVS EPS — quarterly 2.33
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 1.65 | — | — | — |
| Aug 5, 2026 | Jun 30, 2026 | 1.85 | 2.58 | +0.73 | +39.46% |
| May 6, 2026 | Mar 31, 2026 | 2.18 | 2.57 | +0.39 | +17.89% |
| Feb 10, 2026 | Dec 31, 2025 | 1.00 | 1.09 | +0.09 | +9.00% |
| Oct 29, 2025 | Sep 30, 2025 | 1.37 | 1.60 | +0.23 | +16.79% |
| Jul 31, 2025 | Jun 30, 2025 | 1.46 | 1.81 | +0.35 | +23.97% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | Leerink Partners | main | Outperform | Outperform |
| Sep 3, 2026 | UBS | main | Buy | Buy |
| Aug 19, 2026 | Argus Research | main | Buy | Buy |
| Aug 12, 2026 | JP Morgan | main | Overweight | Overweight |
| Aug 6, 2026 | UBS | main | Buy | Buy |
| Aug 6, 2026 | Evercore ISI Group | main | Outperform | Outperform |
About CVS Health Corporation
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Country
- United States
- Website
- cvshealth.com
News
- Countdown to CVS Health (CVS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
- Drug Middlemen Face New Transparency Rules as Trump Administration Targets Hidden Fees, Rebates and Spread Pricing: Report
- CVS Q3 Preview: Accelerating Growth, Near 3% Yield, Meaningful Upside Long-Term
- Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet
- CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors
- Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?
- CVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS
- Should You Buy CVS Health Stock While It's Under $100?
- CVS Health Q3 Earnings Preview: How to Approach the Stock?
- Aetna Provider Survey Shows Payer-Provider Trust Remains Strong; Providers say Reducing Fraud can Significantly Lower Health Care Costs
Your note
Sign in to keep a note on CVS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROWN C DAVID II | Director | Stock Award(Grant) | May 13, 2026 | 129,316 |
| CAPOZZI HEIDI B | Officer | Stock Award(Grant) | Mar 30, 2026 | 97,473 |
| COMPTON-PHILLIPS AMY | Officer | Stock Award(Grant) | Mar 30, 2026 | 58,660 |
| COWHEY THOMAS F. | Chief Financial Officer | Stock Award(Grant) | Mar 31, 2025 | 91,297 |
| FARAH ROGER N | Director | Stock Award(Grant) | Nov 28, 2024 | 54,249 |
| JOYNER JOHN DAVID | Chief Executive Officer | Stock Award(Grant) | Mar 30, 2026 | 231,209 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.63% | 123,223,409 | 11.15B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.51% | 83,315,369 | 7.54B | Jun 29, 2026 |
| Capital World Investors | 5.86% | 74,951,955 | 6.78B | Jun 29, 2026 |
| State Street Corporation | 4.71% | 60,283,408 | 5.45B | Jun 29, 2026 |
| Dodge & Cox Inc. | 3.91% | 50,012,765 | 4.52B | Jun 29, 2026 |
| Wellington Management Group, LLP | 2.64% | 33,801,113 | 3.06B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 40,502,867 | 3.66B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59% | 33,064,695 | 2.99B | Jun 29, 2026 |
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 2.48% | 31,708,094 | 2.87B | Jun 29, 2026 |
| WASHINGTON MUTUAL INVESTORS FUND | 2.47% | 31,634,083 | 2.86B | Sep 29, 2026 |
| Income Fund of America | 1.85% | 23,692,996 | 2.14B | Sep 29, 2026 |
| AMERICAN BALANCED FUND | 1.33% | 17,065,948 | 1.54B | Sep 29, 2026 |